Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2026-01-28

Clinical Trial Update: Tamsulosin and the Risk of Serious Adverse Events

View source ↗

Summary

This clinical trial update discusses the risk of serious adverse events associated with tamsulosin in patients with chronic kidney disease. The study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin (tamsulosin)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Chronic Kidney Disease (CKD) | Status: COMPLETED